How much is Inflammatix worth in 2026?

Inflammatix has a current valuation of N/A based on their Later Stage VC round and secondary market data.

How much funding has Inflammatix raised?

Inflammatix has raised $213.5M in total funding across 2 funding rounds.

Inflammatix

Diagnostic EquipmentWebsite

Inflammatix valuation and funding history | Last updated: September 12, 2024 | 2 funding rounds

Current Valuation

N/A

As of September 12, 2024

Total Funding Raised

$213.5M

Across 2 rounds

Last Round

Later Stage VC

$57.0M

Last Funding

Sep 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
September 12, 2024	Later Stage VC (Series E)	$57.0M	N/A	-
September 14, 2021	Later Stage VC (Series D)	$102.4M	N/A	-

Valuation Analysis

Current Valuation Metrics

Inflammatix is currently valued at N/A as of September 12, 2024. The company has raised a total of $213.5M in funding across 2 funding rounds.

Track Inflammatix Valuation Updates

Get notified when Inflammatix raises new funding or valuation changes

Explore More Data

Detailed analysis for Inflammatix

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Inflammatix's valuation history, funding rounds, and growth metrics.

No credit card required

What is Inflammatix Worth in 2026?

Inflammatix is a leading private company in the Diagnostic Equipment sector. Track Inflammatix's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Inflammatix Valuation is Determined

Private company valuations like Inflammatix's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.